|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
6
|
Zenith Epigenetics
|
Nov 20, 2018 03:23PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
6
|
Zenith Epigenetics
|
Sep 26, 2024 11:51AM
|
|
Re: Richmond Club presentation
|
6
|
Resverlogix Corp.
|
Mar 30, 2016 04:47PM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 06:29PM
|
|
Re: A comment about market penetration
|
6
|
Resverlogix Corp.
|
Mar 20, 2017 04:25PM
|
|
Re: My conversation with Don....
|
6
|
Resverlogix Corp.
|
Dec 02, 2017 12:05PM
|
|
Thoughts on ZCC
|
6
|
Zenith Epigenetics
|
Sep 02, 2021 12:22PM
|
|
Voting reminder
|
6
|
Resverlogix Corp.
|
Jun 08, 2023 12:39PM
|
|
Re: Something Doesn't Add Up
|
6
|
Resverlogix Corp.
|
Aug 17, 2015 11:05AM
|
|
Re: Round one
|
6
|
Resverlogix Corp.
|
Jan 27, 2022 01:17PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
6
|
Resverlogix Corp.
|
Jun 13, 2023 09:08AM
|
|
Thoughts re FDA approvals
|
6
|
Resverlogix Corp.
|
Nov 23, 2015 07:32PM
|
|
Re: Enthusiasm? NOT!
|
6
|
Zenith Epigenetics
|
Oct 30, 2021 12:56PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
6
|
Resverlogix Corp.
|
Sep 06, 2017 04:59PM
|
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 25, 2021 01:09PM
|
|
Covid
|
6
|
Resverlogix Corp.
|
Aug 12, 2022 12:09PM
|
|
Re: Long term risks associated with covid
|
6
|
Resverlogix Corp.
|
Jan 06, 2022 12:23PM
|
|
Re: Just back from IR,...
|
6
|
Resverlogix Corp.
|
Oct 26, 2019 11:07AM
|
|
Re: Looks like...
|
6
|
Resverlogix Corp.
|
Feb 03, 2021 11:50AM
|
|
Re: Where's the kool aid gang?
|
6
|
Resverlogix Corp.
|
May 20, 2022 05:43PM
|
